Interleukin 10 gene transfer prevents experimental colitis in rats.
about
Intestinal nematode infection ameliorates experimental colitis in miceTransfection of IL-10 expression vectors into endothelial cultures attenuates alpha4beta7-dependent lymphocyte adhesion mediated by MAdCAM-1Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector.Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyThe relationship between the immune system and oral manifestations of inflammatory bowel disease: a reviewProduction of MDC/CCL22 by human intestinal epithelial cellsImmune therapy in inflammatory bowel disease and models of colitis.Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitisc-Maf regulates IL-10 expression during Th17 polarizationPolymorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn's disease.Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel diseaseReview article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis.Stat4 is critical for the balance between Th17 cells and regulatory T cells in colitisEffects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitisCeliac disease: a model autoimmune disease with gene therapy applications.Gene transfer approaches for the treatment of inflammatory bowel disease.Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis.Interleukin-10-based therapy for inflammatory bowel disease.Interleukin 37 expression protects mice from colitis.Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease.Interleukin-10 gene polymorphisms are associated with Behcet's disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han populationIL-10 and its related cytokines for treatment of inflammatory bowel disease.Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.Novel drug delivery strategies for the treatment of inflammatory bowel disease.Innovative therapeutics for inflammatory bowel diseaseInterspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles.Mentation on the immunological modulation of gastrointestinal motility.Regulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment.Gene and cell therapy based treatment strategies for inflammatory bowel diseases.Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.Why interleukin-10 supplementation does not work in Crohn's disease patients.Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease.Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy.Oral nucleic acid therapy using multicompartmental delivery systems.Engineered E. coli delivers therapeutic genes to the colonic mucosa.Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility.Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.IL-10 therapy in Crohn's disease: at the crossroads. Treatment of Crohn's disease with the anti-inflammatory cytokine interleukin 10.Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis.Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model.
P2860
Q24537646-66743997-CB13-4333-92AF-0C3F3F822DDCQ24805188-31A1CC12-C0A7-44F7-875D-4D4E4487B5C2Q24812028-0BEF9F45-6D89-4FC7-B390-514581E5B058Q26801150-074299E4-027A-4FA9-BA91-BD03877AD098Q28078219-663FAC5B-3018-45FF-8589-01D35C824AAFQ28188916-5A85B6E6-20FA-4E94-92A8-DD4230B62F0CQ30774968-E7453EA6-3667-466D-8AA7-D88D604D987DQ33629946-697B4DB2-8931-4E59-A614-76785ED37FA6Q33709726-6E17E147-D700-41C6-9F49-CB87B7FEC035Q33788228-7D2847B0-BBCE-428F-AFB1-58BD0A307BC5Q34553476-A30F1852-56FF-49B7-BBC8-547CECD41531Q34669243-3D12B25E-3E93-4A88-874B-FBFB6B0FDD5CQ34995567-FC6383AD-63E0-406F-86FE-91CA40F34140Q35062006-C64F055A-CC18-41ED-94E6-7BE95CD6DF38Q35122155-8F58B8E2-B8D2-4F77-9CB5-96476861F0D1Q35122162-5AB78318-8C25-4A22-ACB8-0A078732D091Q35142393-B0E78380-3D99-4E92-8AF1-DDC31AB990BCQ35184708-6703F0A0-BA97-4391-A3F7-FC8779789896Q35289509-98B85E94-C37A-459E-970F-5C07C1CB1A6EQ35594252-6E62BA89-C434-406B-A7C3-05C7FE973C27Q35645864-1910B0A6-CC2C-420E-B214-90C88CA93D58Q35678651-A8B0F88B-B58E-412C-8ACE-BD945A3D875CQ36002746-7770D845-B9CC-4044-926B-E3EBCAE5DFFFQ36316765-05ACE2C9-A5DC-45B0-A22A-517BAEBB8097Q36802524-F1E2709E-EB58-4F08-B1F4-A05227CF4357Q36853829-ABD2FC68-D0A4-48AA-9D3B-11EE4425A967Q37134553-15F57C9A-E713-43CA-9AE1-A517D045B628Q37581433-18DB6D77-C69F-4DE7-8AAE-FB81F96F73FEQ37969759-924B2D81-4CBB-42D7-AD06-C39B3246835EQ38034469-C8F3E4B8-7F94-4690-8725-709028920986Q38120519-CB91CC5D-CCA7-46A8-957B-90EEC86492CBQ38597023-07686487-460F-493A-9059-39601487EC46Q38963728-49D66CF3-D237-4C9C-AA75-A315B0E6B26DQ39330117-E455F4BF-9C13-4BF8-9AAF-9C7A2413B331Q41458834-4FDB15BE-D7AB-4929-8CAF-92B790B7939EQ41952084-9B001746-571C-40B9-8F70-62505AC6D8CEQ41981077-4B6E9F5D-69DB-4946-866E-EDE33EF4441AQ42150160-8C4D3C9F-575C-4CD1-9B7E-F02C6DE3E7AAQ43263394-1EABF1EF-36B0-475B-8CE1-6BBE78C8CA35Q43782313-C3B18A8B-A88D-49AE-BFBD-4D80D1B99E37
P2860
Interleukin 10 gene transfer prevents experimental colitis in rats.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Interleukin 10 gene transfer prevents experimental colitis in rats.
@en
Interleukin 10 gene transfer prevents experimental colitis in rats.
@nl
type
label
Interleukin 10 gene transfer prevents experimental colitis in rats.
@en
Interleukin 10 gene transfer prevents experimental colitis in rats.
@nl
prefLabel
Interleukin 10 gene transfer prevents experimental colitis in rats.
@en
Interleukin 10 gene transfer prevents experimental colitis in rats.
@nl
P2093
P2860
P356
P1433
P1476
Interleukin 10 gene transfer prevents experimental colitis in rats.
@en
P2093
P2860
P304
P356
10.1136/GUT.46.3.344
P407
P577
2000-03-01T00:00:00Z